Vet dose has always been 3 mg/kg once weekly for four weeks with 80% patients returning a very positive response. It was always stressed by the manufacturer that this was a 'sweet spot' dose, higher or lower and we could expect diminished responses. Can't remember the rationale for that but there was one.
- Forums
- ASX - By Stock
- PAR
- Ann: PAR Reports Successful Primary Endpoint in Phase 2 Trial
Ann: PAR Reports Successful Primary Endpoint in Phase 2 Trial, page-41
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
29.8¢ |
Change
0.003(0.85%) |
Mkt cap ! $103.1M |
Open | High | Low | Value | Volume |
30.0¢ | 30.0¢ | 29.5¢ | $34.53K | 115.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 40539 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 101 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 50607 | 0.295 |
8 | 46631 | 0.290 |
5 | 61933 | 0.285 |
4 | 108745 | 0.280 |
3 | 13893 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 6265 | 6 |
0.305 | 30425 | 5 |
0.310 | 32207 | 3 |
0.315 | 59184 | 6 |
0.320 | 122010 | 6 |
Last trade - 15.56pm 22/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |